Cellcentric has raised $220 million in financing to support two clinical trials testing its potentially first-in-class oral therapy inobrodib in people with hard-to-treat…
Myeloma
My very first journalism teacher, way back in high school, taught me the importance of “who, what, when, where, and why” as building blocks of…
When I wake up some mornings, I check on my mum to see how she’s faring. Then I mentally review two different calendars. One of…
Gilead said it has completed its $7.8 billion acquisition of Arcellx, a deal the company hopes will allow it to streamline and accelerate the…
Note: This column describes the author’s experience with Revlimid (lenalidomide). Not everyone will have the same response to treatment. Consult your doctor before starting or…
Some days when I’m caregiving for my mum, I’ve noticed that the hardest part isn’t what one might expect. The hardest part doesn’t have anything…
The Center for Cancer and Blood Disorders (CCBD), a network of community-based oncology practices across Maryland, has launched a program to make CAR…
Have you seen “The Pitt?” The medical drama on HBO Max is not for the faint of heart as it races from case…
It started with bruises on my mum’s arms. They were small, purple, and red, as if she had fallen down. While we were still trying…
The U.S. Food and Drug Administration (FDA) has granted fast track status to Opna Bio‘s OPN-6602 as a potential treatment for people…
